JP2012516347A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012516347A5 JP2012516347A5 JP2011548281A JP2011548281A JP2012516347A5 JP 2012516347 A5 JP2012516347 A5 JP 2012516347A5 JP 2011548281 A JP2011548281 A JP 2011548281A JP 2011548281 A JP2011548281 A JP 2011548281A JP 2012516347 A5 JP2012516347 A5 JP 2012516347A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- phenothiazine
- soluble
- water
- residue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 59
- 125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 claims description 25
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 claims description 10
- 229950000688 phenothiazine Drugs 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 8
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 8
- 125000000623 heterocyclic group Chemical group 0.000 claims description 6
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 6
- 229920000233 poly(alkylene oxides) Polymers 0.000 claims description 6
- 125000006850 spacer group Chemical group 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 239000000178 monomer Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 claims description 2
- HOKDBMAJZXIPGC-UHFFFAOYSA-N Mequitazine Chemical compound C12=CC=CC=C2SC2=CC=CC=C2N1CC1C(CC2)CCN2C1 HOKDBMAJZXIPGC-UHFFFAOYSA-N 0.000 claims description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 230000008878 coupling Effects 0.000 claims description 2
- 238000010168 coupling process Methods 0.000 claims description 2
- 238000005859 coupling reaction Methods 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 229960005042 mequitazine Drugs 0.000 claims description 2
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 229960003910 promethazine Drugs 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 238000000034 method Methods 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14801609P | 2009-01-28 | 2009-01-28 | |
| US61/148,016 | 2009-01-28 | ||
| PCT/US2010/022342 WO2010088340A1 (en) | 2009-01-28 | 2010-01-28 | Oligomer-phenothiazine conjugates |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012516347A JP2012516347A (ja) | 2012-07-19 |
| JP2012516347A5 true JP2012516347A5 (enExample) | 2013-03-14 |
| JP5828587B2 JP5828587B2 (ja) | 2015-12-09 |
Family
ID=42101449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011548281A Active JP5828587B2 (ja) | 2009-01-28 | 2010-01-28 | オリゴマー−フェノチアジン結合体 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20120046279A1 (enExample) |
| EP (1) | EP2391386B1 (enExample) |
| JP (1) | JP5828587B2 (enExample) |
| CN (1) | CN102300588B (enExample) |
| AU (1) | AU2010208274B2 (enExample) |
| CA (1) | CA2749126C (enExample) |
| MX (1) | MX2011007940A (enExample) |
| WO (1) | WO2010088340A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101878042B (zh) * | 2007-11-28 | 2013-06-19 | 尼克塔治疗公司 | 低聚物-三环共轭物 |
| US20120046279A1 (en) | 2009-01-28 | 2012-02-23 | Nektar Therapeutics | Oligomer-Phenothiazine Conjugates |
| WO2011091050A1 (en) * | 2010-01-19 | 2011-07-28 | Nektar Therapeutics | Oligomer-tricyclic conjugates |
| EP2758403B1 (en) | 2011-09-21 | 2016-04-27 | Inception Orion, Inc. | Tricyclic compounds useful as neurogenic and neuroprotective agents |
| JP6265998B2 (ja) * | 2012-09-17 | 2018-01-24 | ネクター セラピューティクス | オリゴマー含有ベンズアミド系化合物 |
| US9695138B1 (en) | 2016-10-17 | 2017-07-04 | Acenda Pharma, Inc. | Phenothiazine derivatives and methods of use thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2607773A (en) | 1952-08-19 | Processes for preparing phenthi- | ||
| US2519886A (en) | 1950-08-22 | Beta-bimethylaminoethylphenothia | ||
| US2530451A (en) | 1950-11-21 | Phenothiazines | ||
| GB641452A (en) | 1946-12-09 | 1950-08-09 | Rhone Poulenc Sa | Improvements in or relating to the preparation of derivatives of phenthiazine |
| US3987042A (en) | 1969-03-03 | 1976-10-19 | Claude Gueremy | Phenothiazine derivative |
| FR2632521B1 (fr) | 1988-06-10 | 1990-09-14 | Rhone Poulenc Sante | Nouveaux derives de la phenothiazine, leur preparation et les compositions pharmaceutiques qui les contiennent |
| US5672662A (en) | 1995-07-07 | 1997-09-30 | Shearwater Polymers, Inc. | Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications |
| EP1360180A1 (en) | 2001-01-19 | 2003-11-12 | Cytokinetics, Inc. | Phenothiazine kinesin inhibitors |
| US6835802B2 (en) | 2001-06-04 | 2004-12-28 | Nobex Corporation | Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties |
| US7122201B2 (en) | 2001-06-28 | 2006-10-17 | Baxter International Inc. | Composition and method for reducing adverse interactions between phenothiazine derivatives and plasma using surfactants and amino acids |
| AR047938A1 (es) * | 2003-08-25 | 2006-03-15 | Combinatorx Inc | Formulaciones, conjugados y combinaciones de farmacos para el tratamiento de neoplasmas |
| EP2905033B1 (en) | 2003-12-16 | 2020-09-02 | Nektar Therapeutics | Monodisperse PEGylated naloxol compositions |
| US20080112257A1 (en) * | 2006-11-10 | 2008-05-15 | Masatoshi Masuda | Mixing device for tub |
| EP2500039A1 (en) * | 2007-03-12 | 2012-09-19 | Nektar Therapeutics | Oligomer-antihistamine conjugates |
| US20120046279A1 (en) | 2009-01-28 | 2012-02-23 | Nektar Therapeutics | Oligomer-Phenothiazine Conjugates |
-
2010
- 2010-01-28 US US13/146,612 patent/US20120046279A1/en not_active Abandoned
- 2010-01-28 AU AU2010208274A patent/AU2010208274B2/en active Active
- 2010-01-28 JP JP2011548281A patent/JP5828587B2/ja active Active
- 2010-01-28 CN CN201080005673.6A patent/CN102300588B/zh active Active
- 2010-01-28 CA CA2749126A patent/CA2749126C/en active Active
- 2010-01-28 MX MX2011007940A patent/MX2011007940A/es active IP Right Grant
- 2010-01-28 EP EP10703204.7A patent/EP2391386B1/en active Active
- 2010-01-28 WO PCT/US2010/022342 patent/WO2010088340A1/en not_active Ceased
-
2018
- 2018-05-01 US US15/968,561 patent/US10485877B2/en active Active
-
2019
- 2019-10-11 US US16/599,605 patent/US10869933B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012516347A5 (enExample) | ||
| JP5249016B2 (ja) | タキサン類の高分子結合体 | |
| CN103221067B (zh) | 磷脂药物类似物 | |
| JP2010527913A5 (enExample) | ||
| JP2011530597A5 (enExample) | ||
| JP2012017342A5 (enExample) | ||
| JP2013523896A5 (enExample) | ||
| JP2018518201A5 (enExample) | ||
| JP2020536847A5 (enExample) | ||
| JP2008542285A5 (enExample) | ||
| JP2012502990A5 (enExample) | ||
| JP2020536845A5 (enExample) | ||
| JP2011528654A5 (enExample) | ||
| JPWO2008010463A1 (ja) | コンブレタスタチン類の高分子結合体 | |
| JP2011511075A5 (enExample) | ||
| JP2011092201A5 (enExample) | ||
| JP2013525080A5 (enExample) | ||
| JP2013518832A5 (enExample) | ||
| JP2013525414A5 (enExample) | ||
| JP2014503548A5 (enExample) | ||
| JP2008266635A5 (ja) | 活性エネルギー線硬化型液体組成物、水性インク及び液体カートリッジ | |
| JP2010505865A5 (enExample) | ||
| AU2017279536A1 (en) | Non-cleavable polymer conjugated with αvβ3 integrin thyroid antagonists | |
| US7625898B2 (en) | Posaconazole polymer conjugates and methods of treatment using posaconazole and polymer conjugates thereof | |
| JP2008545718A5 (enExample) |